Amgen has laid off roughly 300 U.S. employees or about 1.2% of its total workforce, amid organizational changes to its commercial team, Reuters’ Bhanvi Satija reports. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AMGN:
- Can Amgen (AMGN) Q4 Earnings Beat Street Expectations?
- Warren writes FTC over concerns of two pharma deals, Reuters reports
- Amgen price target cut at Piper on lower Otezla estimates
- Illumina, Nashville Biosciences announce sequencing agreement with Amgen
- Research raises ‘valid questions’ about Amgen’s Repatha, says Barclays